CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-03-05 | Hakim Nasrat A President & CEO | Grant or award | +2,046,554 | $0.34 | $700K | 13,760,695 |
| 2015-01-06 | NIGALAYE ASHOK G Director | Conversion · Warrants | −1,500,000 | $0.06 | $94K | 2,924,333 |
| 2015-01-06 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion | +2,833,333 | $0.06 | $177K | 17,108,622 |
| 2015-01-06 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion · Warrants | −1,333,333 | $0.06 | $83K | 0 |
| 2015-01-06 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion · Warrants | −1,500,000 | $0.06 | $94K | 8,622,043 |
| 2014-10-17 | Hakim Nasrat A CEO & President | Other acquisition · Warrants | +759,695 | 759,695 | ||
| 2014-10-17 | NARINE JEENARINE Director | Other disposition · Warrants | −20,000,002 | 6,726,999 | ||
| 2014-10-17 | NARINE JEENARINE Director | Other acquisition · Warrants | +4,178,320 | 8,602,653 | ||
| 2014-10-17 | NIGALAYE ASHOK G Chief Scientific Officer | Other disposition · Warrants | −20,000,002 | 6,726,999 | ||
| 2014-10-17 | NIGALAYE ASHOK G Chief Scientific Officer | Other acquisition · Warrants | +5,697,710 | 10,122,043 | ||
| 2014-10-17 | EPIC PHARMA LLC 10% owner | Other disposition · Warrants | −20,000,002 | 6,726,999 | ||
| 2014-04-02 | NARINE JEENARINE Director | Sale | +147,667 | $0.41 | $61K | 5,682,877 |
| 2014-04-01 | NARINE JEENARINE Director | Sale | −157,012 | $0.41 | $65K | 5,830,544 |
| 2013-07-23 | Plassche Douglas Senior VP of Operations | Grant or award · Options | +3,000,000 | 3,000,000 | ||
| 2013-04-29 | NIGALAYE ASHOK G Chief Scientific Officer | Returned to the company | −140,000 | $0.08 | $11K | 30,366,536 |
| 2013-04-29 | NARINE JEENARINE Director | Returned to the company | −140,000 | $0.08 | $11K | 24,268,978 |
| 2013-04-29 | POTTI RAM Director | Returned to the company | −140,000 | $0.08 | $11K | 24,538,536 |
| 2013-04-29 | EPIC PHARMA LLC 10% owner | Returned to the company | −140,000 | $0.08 | $11K | 9,399,712 |
| 2013-04-29 | EPIC INVESTMENTS, LLC 10% owner | Returned to the company | −140,000 | $0.08 | $11K | 9,399,712 |
Page 8 of 8 · 159 trades